home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Advances in cancer therapeutics

 
  August 09, 2004  
     
 
Graduate College 460, University of Ulm, Ulm, Germany
2004-10-14


07:30 Registration

08:30 Welcome

08:45 Cancer gene therapy
Jarmo Wahlfors
University of Kuopio, Finland

09:45 RNAi applications to study cancer
Reuven Agami
The Netherlands Cancer Institute, The Netherlands

10:45 German breakfast, poster viewing

11:10 Complexities of angiogenesis: what can we learn from fish,
frogs and mice?
Edward Conway
University of Leuven, Belgium

12:10 Cancer immune therapy
Paul Moss
University of Birmingham, United Kingdom

13:10 Lunch, poster discussion

15:00 p53 from pathway to cancer therapy
Jean-Christophe Marine
University of Gent, Belgium

16:00 Four oral presentations
Young researchers

17:00 Coffee break

17:30 Four oral presentations
Young researchers

18:30 Farewell

18:40 Poster prize

18:50 Dinner party

 
 
Organized by: Graduate College 460, University of Ulm, Germany
Invited Speakers: Jarmo Wahlfors (University of Kuopio, Finland);
Reuven Agami (The Netherlands Cancer Institute,
The Netherlands);
Edward Conway (University of Leuven, Belgium);
Paul Moss (University of Birmingham, United Kingdom);
Jean-Christophe Marine (University of Gent, Belgium).


 
Deadline for Abstracts: 2004-08-20
 
Registration: This event is a continuation of former three annual scientific symposiums organised by the students of Graduate College 460. In 2004 we seek to bring together young researchers and internationally renowned keynote speakers by addressing one of the hottest areas in clinical research - cancer therapeutics. PhD and MD students in the field of cancer research are welcome to apply by submitting an abstract for a poster session (30 posters). In addition, eight posters will be selected for a 10-minute oral presentation. Graduate students in other fields can also apply by submitting an abstract. These poster presentations are limited to 20 applicants. We will also consider a number of applicants without an abstract. The participation is limited to 150 people. Competition in science is one way of guaranteeing success. Hence, a jury consisting of keynote speakers will award a prize for the best poster communicated by a young researcher. Please register by sending your abstract to:
E-mail: jon.genuneit@medizin.uni-ulm.de
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.